Chapter2. CONTROLLED SUBSTANCES.  


Article 1. General Provisions.
§ 20-2-1. Short title.
§ 20-2-2. Definitions.
§ 20-2-3. Immunity of persons reporting suspected use, etc., of controlled substance by minor child.
Article 2. Standards and Schedules.
§ 20-2-20. Administration of chapter.
§ 20-2-21. Nomenclature of controlled substances in schedules.
§ 20-2-22. Schedule I - Standards for compilation.
§ 20-2-23. Schedule I - Listing of controlled substances.
§ 20-2-24. Schedule II - Standards for compilation.
§ 20-2-25. Schedule II - Listing of controlled substances.
§ 20-2-26. Schedule III - Standards for compilation.
§ 20-2-27. Schedule III - Listing of controlled substances.
§ 20-2-28. Schedule IV - Standards for compilation.
§ 20-2-29. Schedule IV - Listing of controlled substances.
§ 20-2-30. Schedule V - Standards for compilation.
§ 20-2-31. Schedule V - Listing of controlled substances.
§ 20-2-32. Revision and republication of schedules.
Article 3. Regulation of Manufacture and Distribution.
§ 20-2-50. Certifying boards to promulgate rules and charge reasonable fees for registration and administration of provisions relating to manufacture, etc., of controlled substances; disposition of fees collected.
§ 20-2-51. Registration of persons manufacturing, distributing or dispensing controlled substances - General requirements.
§ 20-2-52. Registration of persons manufacturing, distributing or dispensing controlled substances - Standards; requirements as to practitioners conducting research; effect of federal registration.
§ 20-2-53. Registration of persons manufacturing, distributing or dispensing controlled substances - Order to show cause; proceedings; review; issuance of stay.
§ 20-2-54. Registration of persons manufacturing, distributing or dispensing controlled substances - Revocation or suspension of registration - Grounds and procedure generally.
§ 20-2-54.1. Rules and regulations.
§ 20-2-55. Registration of persons manufacturing, distributing or dispensing controlled substances - Revocation or suspension of registration - Suspension without prior order to show cause.
§ 20-2-56. Maintenance of records and inventories by registrants generally.
§ 20-2-57. Distribution of certain controlled substances by one registrant to another registrant.
§ 20-2-58. Dispensing of controlled substances in Schedule II; maintenance of records and inventories by registered pharmacies.
Article 3A. Assistants to Physcians Authority to Prescribe Controlled Substances.
§ 20-2-60. Definitions.
§ 20-2-61. Certification; access to records; establishment of protocols, formularies, or medical regimens.
§ 20-2-62. Qualifications for certificate.
§ 20-2-63. Prescriptive authority of a certified assistant to physician.
§ 20-2-64. Denial of application.
§ 20-2-65. Disciplinary action - Hearing; restriction, suspension, or revocation of certificate.
§ 20-2-66. Disciplinary action - Judicial review.
§ 20-2-67. Fees; costs; administrative fines.
§ 20-2-68. Liability for actions regarding investigations or disciplinary proceedings.
§ 20-2-69. Promulgation of rules.
Article 4. Offenses and Penalties.
§ 20-2-71. Prohibited acts B.
§ 20-2-72. Prohibited acts C.
§ 20-2-74. Prescription, administration, etc., of controlled substances by practitioners of veterinary medicine for use of human beings or by practitioners of dentistry for persons not under treatment in regular practice of profession.
§ 20-2-78. Penalties imposed for violations of chapter in addition to other civil or administrative penalties or sanctions.
Article 4A. Trafficking in Illegal Drugs.
Article 5. Enforcement.
§ 20-2-90. State Board of Pharmacy, Department of Public Safety, etc., to enforce chapter; drug inspectors to meet minimum standards.
§ 20-2-91. Inspection of stocks of controlled substances and prescriptions, orders, etc., required by chapter; disclosure of information as to prescriptions, orders, etc., by enforcement personnel.
§ 20-2-92. Injunctions.
§ 20-2-93. Forfeitures; seizures.
Article 6. Therapeutic Research.
§ 20-2-110. Short title.
§ 20-2-111. Legislative findings; cannabis research.
§ 20-2-112. Definitions.
§ 20-2-113. Controlled Substances Therapeutic Research Program - Established; review committee; rules and regulations; formulation with federal agencies.
§ 20-2-114. Controlled Substances Therapeutic Research Program - Limited to cancer chemotherapy and glaucoma patients; certification; exemption from prosecution.
§ 20-2-115. Composition of review committee.
§ 20-2-116. Certification in subspecialty of oncology required; certification by State Board of Medical Examiners; recertification.
§ 20-2-117. Contracts for receipt of cannabis; Board of Medical Examiners to promulgate guidelines, rules and regulations.
§ 20-2-118. Annual reports to Governor and Legislature.
§ 20-2-119. Enumeration as Schedule I or II substance inapplicable.
§ 20-2-120. Penalties.
Article 7. Imitation Controlled Substances.
§ 20-2-140. Short title.
§ 20-2-141. Definitions.
§ 20-2-142. Legislative intent.
§ 20-2-143. Manufacture, distribution, possession, or advertisement of imitation controlled substances prohibited; penalties; immunity of certain persons from liability.
§ 20-2-144. Exceptions.
Article 8. Solicitation, Attempt and Conspiracy to Commit Controlled Substance Crime.
Article 9. Precursor Chemicals.
§ 20-2-180. Definitions.
§ 20-2-181. Board to designate by rule listed precursor chemicals; interim list established.
§ 20-2-182. License required for furnishing listed precursor chemical; licensing procedure; record of transactions.
§ 20-2-183. Permit for possession; requirements to receive permit; copies.
§ 20-2-184. Denial, suspension or revocation of license.
§ 20-2-185. Reporting transactions - Board to supply form.
§ 20-2-186. Procedure upon discovery of loss or theft of chemicals - Records - Audits and inspections of records.
§ 20-2-187. Adoption of rules; administrative fees authorized.
§ 20-2-188. Exceptions to requirements for sale or transfer of chemicals, and to licensing requirements.
§ 20-2-189. Property rights in chemicals forfeited upon violation.
§ 20-2-190. Penalties; sale of ephedrine, etc.; Alabama Drug Abuse Task Force.
§ 20-2-190.1. Legislative intent.
§ 20-2-190.2. Electronic drug offender tracking system.
Article 10. Controlled Substances Prescription Database.
§ 20-2-210. Legislative findings.
§ 20-2-211. Definitions.
§ 20-2-212. Controlled substances prescription database program; powers and duties of department; trust fund; committee membership and meetings.
§ 20-2-213. Reporting requirements.
§ 20-2-214. Limited access to database permitted for certain persons or entities.
§ 20-2-215. Confidentiality of database.
§ 20-2-216. Unauthorized disclosure of information; unauthorized access, alteration, or destruction of information.
§ 20-2-217. Surcharge on controlled substance registration certificate.
§ 20-2-218. Reimbursement of certain costs incurred in compliance with article.
§ 20-2-219. Database funding.
§ 20-2-220. Liability for reporting.
Article 11. Prescribing of Certain Schedules of Controlled Substances by Certified Registered Nurse Practitioners and Certified Nurse Midwives.
§ 20-2-250. Definitions.
§ 20-2-251. Certifying board; advisory committee; access to records; protocols, formularies, medical regimens.
§ 20-2-252. Certificate requirements.
§ 20-2-253. Prescription, administration, dispensing of controlled substances.
§ 20-2-254. Grounds for denial of application or request for renewal, etc.
§ 20-2-255. Hearings; restriction, suspension, revocation of certificate.
§ 20-2-256. Judicial review.
§ 20-2-257. Fees.
§ 20-2-258. Liability.
§ 20-2-259. Rules.
Article 12. Limited Purpose Schedule II Permit.
§ 20-2-260. Permit authorized.